Shots: The Multiple Studies P-III ECHELON-1 (Adcetris + CT vs CT), P-I/II & P-II (Adcetris + Opdivo(nivolumab)) and P-III AETHERA (Adcetris) is evaluated in patients with stage III or IV HL, r/r HL and HL at Risk of Relapse or Progression respectively Results of P-III ECHELON-1: superior PFS with safety and efficacy: P-I/II & P-II: […]Read More
Tags : ISHL 2018
Latest Posts
Categories
Related Topics
AbbVie
Acquire
Adults
Agreement
Amgen
approval
AstraZeneca
Bayer
Biosimilar
BMS
Collaborate
Collaborates
Collaboration
Commercialize
COVID-19
Develop
Development
Eli Lilly
EU
Exclusive
FDA
Gilead
GSK
Janssen
Launches
License
License Agreement
Merck
Novartis
P-III
patients
Pfizer
receives
Report
reports
results
Roche
Sanofi
Signs
study
Takeda
the US FDA
Treat
Treatment
US